What remains unknown Despite encouraging data, genuine unknowns exist: Effects beyond 6-9 months of continuous use have not been formally studied in animals or humans
Early intervention is generally associated with better outcomes, and clinicians should not attribute new joint symptoms solely to pre-existing conditions without appropriate reassessment
Peptides for Cognitive Enhancement & Dementia Prevention A review of popular peptides including GLP1-RAs, SS-31, BPC-157, and Cerebrolysin The global peptide therapeutics market was estimated at a whopping $117B in 2024 and is continuing to grow
Specific Antibiotics and Safety Considerations While most antibiotics are considered safe to use with GLP-1s, some specific classes require closer monitoring
However, if you notice an increase in hair shedding after going on semaglutide, the medication may have something to do with it
This content is not a substitute for professional medical advice, diagnosis, or treatment